Want to join the conversation?
During 3Q15, $PFE completed its previously announced acquisition of Hospira. America's largest drug-maker expects the transaction will deliver $800MM in annual cost synergies by 2018. On Sept 30, 2015, $PFE updated certain components of its 2015 financial guidance solely to reflect anticipated impact of Hospira operations on 2015 financial results.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.